CB
Chickadee Biomedicines, Inc.
StreetZero Signal 71
About Chickadee Biomedicines, Inc.
Chickadee Biomedicines, Inc. is a biotechnology operating company incorporated in Delaware in 2025. It is based in Boston, Massachusetts. The company reported a capital raise via SEC EDGAR Form D filing dated June 25, 2026.
LATEST FUNDINGPrivate Placement
$1.0M
Announced 2026-11-10
TOTAL RAISED$150,000
IN THE NEWS
- ๐ Chickadee Biomedicines, Inc. raised $150K | Global Deal Flow
- ๐ Wayward Chickadee - 2026 Company Profile - Tracxn
- ๐ Generate:Biomedicines Announces Close of $273M Series C Financing to Advance Its Generative AI Pipeline of Preclinical and Clinical Protein Therapeutics | Generate:Biomedicines
- ๐ Generate Biomedicines - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- ๐ Biotech Funding 2025 Tracker: Follow the Latest Raises, Rounds and R&D Momentum
EMPLOYEESโ
FOUNDED2025
HQBoston, Massachusetts, US
Industry
Biotechnology
Tags
BiotechnologyPrivate Placement
Investors
Not disclosed in the source filing. Form D filings do not list investors โ StreetZero surfaces them from news where available.
Key highlights
- Reported $150,000 raised via Form D filing in June 2026
- Target raise amount of $1.0M
- Biotechnology sector operating company
- Incorporated in Delaware
Ask StreetZero about Chickadee Biomedicines, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account